Riyaz Ahmad Mir

Dr. Riyaz Ahmad Mir


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

8 April 2024 in Odontology
Verified
Journal Article
Closed access
PDF file
VYVikender Singh Yadav
Vikender Singh Yadav
ABAnu Bhatia
Anu Bhatia
RYRakhee Yadav
Rakhee Yadav
KMKanika Makker
Kanika Makker
DSDhiraj Kumar Singh
Dhiraj Kumar Singh
RMRiyaz Ahmad Mir
Riyaz Ahmad Mir

1 January 2024 in Journal of Applied Biology & Biotechnology
Verified
Journal Article
Open access
PDF file
DSDhiraj Kumar Singh
Dhiraj Kumar Singh
BJBimal Jit
Bimal Jit
RGRashmi Gupta
Rashmi Gupta
AVAmit Kumar Verma
Amit Kumar Verma
RMRiyaz Ahmad Mir
Riyaz Ahmad Mir
R2TP (Rvb1, Rvb2, Tah1, and Pih1) complex was initially discovered as a Heat shock protein 90 associated multimeric protein complex in yeast and is highly conserved in mammals. In Human R2TP complex is known by different names including RUVBL1 for Rvb1, RuvBL2 for Rvb2, RPAP3 (RNA polymerase II-associated protein 3) for Tah1 and PIH1D1 for Pih1, and known to be a specialized Co-chaperone of Hsp-90 protein. This multimeric-protein complex is involved in the assembly and maturation of several multisubunit complexes including RNA polymerase II, small nucleolar ribonucleoproteins, and complexes containing phosphatidylinositol-3-kinase-like kinases. Nevertheless, evidence in the clinical setting is scanty with respect to the expression of PIH1 domain containing 1 (PIH1D1) and its prognostic values in breast cancer (BRCA). Exploring the function of PIH1D1 in BRCA could reveal its therapeutic and translational potential in BRCA. In the current study, we analyzed PIH1D1 expression levels across cancers with the help of a bioinformatics tool and tumor immune estimation resource, and compared with normal and BRCA tissues using tumor, normal, and metastasis plot. Disease-free and overall survival analysis was done by survival plot, in gene expression profiling interactive analysis web server. Furthermore, histological analysis of PIH1D1 protein expression was done with the help of the Human Protein Atlas Database. Clusters and interaction analysis were done using cell line expression cluster toll in Human Protein Atlas. The result of our study shows that PIH1D1 expression was higher in almost all cancer groups and significantly increased in BRCA. Additionally, we found a positive statistical correlation between PIH1D1 and CD4+ and CD8+ T cell infiltration, which is an indication of the immunotherapeutic potential of PIH1D1. The expression of chemokines and receptors was shown to be significantly positively linked with Chemokine (C-C motif) ligand 14 when PIH1D1 was increased. Furthermore, the UALCAN (University of ALabama at Birmingham CANcer) data analysis results also revealed that PIH1D1 was significantly associated with tumor metastasis, menopausal status, grade, and different stages of patients with BRCA. In conclusion, the current study provides the preliminary proof of concept regarding the biomarker potential of PIH1D1. However, further in vivo and in vitro mechanistic studies in detail are required to explore the therapeutic potential of PIH1D1 in BRCA.

11 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDhiraj Kumar
Dhiraj Kumar
PRPrashant Ranjan
Prashant Ranjan
AVAmit Kumar Verma
Amit Kumar Verma
RMRiyaz Ahmad Mir
Riyaz Ahmad Mir
Genetic alterations in normal brain cells lead to the development of brain tumors (BT). The incidence of newly diagnosed cases is on the rise over time. Understanding the molecular biology of pediatric brain tumors is crucial for advancing novel therapeutic approaches to prevent or effectively manage this disease. The R2TP complex, a conserved co-chaperone from yeast to mammals, including RUVBL1, RUVBL2, PIH1D1, and RPAP3 in humans, plays a crucial role in the assembly and maturation of various multi-subunit complexes. This study evaluates the expression of PIH1D1 and p53 in pediatric brain cancers using The Cancer Genome Atlas (TCGA) data through the UALCAN platform—a novel, user-friendly resource for cancer OMICS data analysis. Our analysis revealed elevated expression levels of PIH1D1 in pediatric brain tumors across all age groups compared to normal tissues, suggesting its potential as an early detection marker and a prognostic indicator. Additionally, P53 emerged as a promising target for brain tumor treatment, warranting exploration for age-specific applications. The Venn Diagram analysis further delineated key genes within the PIH1D1 and P53 networks, providing insights into the genetic landscape of childhood brain cancer. Despite these findings, the study has limitations, primarily relying on bioinformatics databases. Future research will incorporate clinical tissues and cell lines in in vivo and in vitro experiments to unravel the mechanistic roles of PIH1D1 and p53 in brain tumors. This comprehensive approach bridges bioinformatics and clinical exploration, contributing to a holistic understanding of pediatric brain cancer molecular biology and paving the way for targeted therapeutic interventions.

5 March 2026 in Virology Journal
Verified
Journal Article
Open access
MSMahaiwon Shadang
Mahaiwon Shadang
AAAruna Arumugam
Aruna Arumugam
DSDhiraj Kumar Singh
Dhiraj Kumar Singh
PKPankaj Keshari
Pankaj Keshari
SMSandeep Mathur
Sandeep Mathur
RMRiyaz Ahmad Mir
Riyaz Ahmad Mir
Human papillomaviruses (HPVs), particularly types 16 and 18, are major contributors to cervical cancer through the oncogenic activities of the E6 and E7 proteins. These viral proteins inactivate the tumour suppressors p53 and pRB, driving uncontrolled cellular proliferation. In this study, we investigated the interaction between the HPV E7 protein and the R2TP complex, a co-chaperone involved in essential cellular functions, including ribosome biogenesis, transcription, and macromolecular assembly. We identified PIH1D1, a core R2TP subunit, as an interacting partner of HPV16 and HPV18 E7 proteins. Mutagenesis and pull-down assays showed that phosphorylation of HPV E7 by casein kinase 2 (CK2) is critical for this interaction, as mutations of serine residues within the CK2 phospho-acceptor site on E7 disrupted the binding with PIH1D1. Furthermore, PIH1D1 facilitated the association of E7 with the retinoblastoma protein (pRB), forming a complex that likely promotes cancer cell proliferation. Immunohistochemical analysis of cervical cancer tissues revealed overexpression of PIH1D1, RUVBL1, and RPAP3—key components of the R2TP complex. Functional assays confirmed that PIH1D1 is crucial for cervical cancer cell growth and migration, as its silencing reduced E7 stability and impaired proliferation. Collectively, these findings highlight that PIH1D1, and by extension, the R2TP complex, is integral to the HPV-driven malignancy and suggest potential as therapeutic targets in HPV-related cancers. Despite being largely preventable through vaccination, cervical cancer is a significant concern for public health. Research is essential to understand the factors contributing to its high incidence and mortality and to devise effective prevention and treatment strategies. We investigated the functional role of PIH1D1, a core subunit of the R2TP complex, in the HPV-mediated cervical carcinogenesis. The interaction of the R2TP complex, HPV E7, and the tumour suppressor pRB proteins may be essential in driving malignant transformation. The online version contains supplementary material available at 10.1186/s12985-026-03070-z.

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDhiraj Kumar Singh
Dhiraj Kumar Singh
QMQulsum Akhter Mir
Qulsum Akhter Mir
RMRiyaz Ahmad Mir
Riyaz Ahmad Mir
The R2TP is a multimeric protein complex consists of RUVBL1, RUVBL2, PIH1D1, and RPAP3, and it is known to functions as a specialized co-chaperone. We hypothesize that PIH1D1 recognizes p53 and stabilizes it via R2TP complex. Upon successful completion of this study, innovative mechanism has been found for the interaction and stabilization of p53 and hence govern the cell cycle. Upon interaction between p53 and PIH1D1 protein, p53 is stabilized by PIH1D1 protein, without affecting its C-terminal domain. We have also observed that p53 protein levels were affected after the alteration in expression levels of PIH1D1. Based on the finding, we suggest that the R2TP complex stabilizes and regulates P53. Therefore, this novel method will work as a flashpoint to restore the function of p53 in cancer cells, controlling cancer and cell cycle progression.